- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 527K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 60.36K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $78.24K |
| Capex | Q1 2026 · Mar 31, 2025 | $64.16K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$122.2K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$449.12K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.25M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.25M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $8.84M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.47M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.51M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.3M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | −$4.57M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$4.64M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $15.66M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $14.4M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $17.09M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $15.88M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $14.38M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $15.48M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $19.6M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $20.18M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$2.75 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$44.24 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$2.75 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$44.24 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $3.18M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.73M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.45M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$2.67M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.29M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$1.23M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.68M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $3.44M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $2.34M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $1.8M |
| Revenue | Q1 2026 · Mar 31, 2026 | $5.02M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $5.24M |